Salmaso Stefano, Schrepfer Rodolfo, Cavallaro Gennara, Bersani Sara, Caboi Francesca, Giammona Gaetano, Tonon Giancarlo, Caliceti Paolo
Department of Pharmaceutical Sciences, University of Padua, Padova, Italy.
Eur J Pharm Biopharm. 2008 Mar;68(3):656-66. doi: 10.1016/j.ejpb.2007.07.004. Epub 2007 Jul 14.
The protein delivery properties of polymer supramolecular assemblies were investigated by using recombinant human growth hormone (rh-GH) and two polyhydroxyethylaspartamide (PHEA) derivatives: (a) PHEA-C16 obtained by PHEA random grafting with hexadecylalkylamine; (b) PHEA-PEG 5000-C16 obtained by PHEA random co-grafting with hexadecylalkylamine and 5 kDa poly(ethylene glycol). The two polymers possessed similar self-assembling properties: critical micelle concentration (CMC) and particle size. The protein loading (protein/polymer, w/w, %) was 12.1+/-1.3% and 8.5+/-0.4% with PHEA-C16 and PHEA-PEG 5000-C16, respectively. The rh-GH/polymer association constant calculated by Scatchard analysis was 1.87 x 10(5)M(-1) with PHEA-C(16) and 0.27 x 10(5)M(-1) with PHEA-PEG 5000-C16. The Klotz analysis showed that 5 PHEA-C16 and 9 PHEA-PEG 5000-C16 polymer chains associated with one protein molecule. The protein dissociation from the PHEA-C16 and PHEA-PEG 5000-C16 supramolecular complexes was complete in about 350-450 and 450-550 h, respectively. With both polymers, the protein release was faster as the protein/polymer ratio increased. Pharmacokinetic studies were performed by subcutaneous administration to rats of protein/polymer solutions at different w/w ratios (1:75 and 1:150). Both polymer formulations slowed the protein absorption. The protein bioavailability increased as the protein/polymer complex stability decreased and the protein/polymer w/w ratio increased indicating that efficient protein delivery can be achieved by proper polymer choice and formulation composition.
通过使用重组人生长激素(rh-GH)和两种聚羟乙基天冬酰胺(PHEA)衍生物,研究了聚合物超分子组装体的蛋白质递送特性:(a)通过PHEA与十六烷基烷基胺随机接枝获得的PHEA-C16;(b)通过PHEA与十六烷基烷基胺和5 kDa聚乙二醇随机共接枝获得的PHEA-PEG 5000-C16。这两种聚合物具有相似的自组装特性:临界胶束浓度(CMC)和粒径。PHEA-C16和PHEA-PEG 5000-C16的蛋白质负载量(蛋白质/聚合物,w/w,%)分别为12.1±1.3%和8.5±0.4%。通过Scatchard分析计算的rh-GH/聚合物缔合常数,PHEA-C16为1.87×10⁵M⁻¹,PHEA-PEG 5000-C16为0.27×10⁵M⁻¹。Klotz分析表明,5条PHEA-C16和9条PHEA-PEG 5000-C16聚合物链与一个蛋白质分子缔合。PHEA-C16和PHEA-PEG 5000-C16超分子复合物中的蛋白质解离分别在约350-450小时和450-550小时内完成。对于这两种聚合物,随着蛋白质/聚合物比例的增加,蛋白质释放更快。通过以不同的w/w比例(1:75和1:150)对大鼠皮下注射蛋白质/聚合物溶液进行了药代动力学研究。两种聚合物制剂均减缓了蛋白质吸收。随着蛋白质/聚合物复合物稳定性降低和蛋白质/聚合物w/w比例增加,蛋白质生物利用度提高,这表明通过适当选择聚合物和制剂组成可以实现有效的蛋白质递送。